In conclusion, in the case of A2058, we could establish proof-of-principle that TMZ treatment triggered the selection of MGMT-positive cells, which were derived from a pre-existing minority of cells that survived and eventually dominated the tumor mass. Here, MGMT is linked to neoplasm.